---
figid: PMC9677952__dic-2022-7-4-g001
pmcid: PMC9677952
image_filename: dic-2022-7-4-g001.jpg
figure_link: /pmc/articles/PMC9677952/figure/f1-dic-2022-7-4/
number: Figure 1
figure_title: ''
caption: Signalling pathways in wild-type and mutant KRAS cells. (A) KRAS plays a
  crucial role in signalling through the MAPK pathway, the PI3K–Akt–mTOR pathway and
  the NF-kB pathway. (B) Mutations in KRAS result in enhanced GTP-loading, causing
  aberrant activation of the MAPK pathway.
article_title: How to manage KRAS G12C-mutated advanced non-small-cell lung cancer.
citation: Biagio Ricciuti, et al. Drugs Context. 2022;11:2022-7-4.
year: '2022'

doi: 10.7573/dic.2022-7-4
journal_title: Drugs in Context
journal_nlm_ta: Drugs Context
publisher_name: BioExcel Publishing Ltd

keywords:
- G12C
- immunotherapy
- KRAS
- NSCLC
- sotorasib

---
